Key result
Greater tricuspid regurgitation severity is linked to ~27% higher all-cause mortality in HFrEF.
Why the study?
The prognostic value of quantitative measures of functional tricuspid regurgitation severity in HFrEF patients was not well established.
Do quantitative measures of functional tricuspid regurgitation severity predict mortality in patients with HFrEF?
Cohort (n=382)
Do quantitative measures of functional tricuspid regurgitation severity predict mortality in patients with HFrEF?
Hazard Ratio: 1.27 (95% CI 1.13–1.42)
p-value: p=<0.001
Quantitative measures of functional TR severity (EROA ≥0.2cm2 and regurgitant volume ≥20ml) are strongly associated with mortality in HFrEF patients, suggesting that current thresholds defining severe TR may need to be lowered.
May refine mortality risk stratification in HFrEF; extends qualitative TR grading but leaves therapeutic implications open.
Objectives To establish the prognostic value of quantitative measures of functional tricuspid regurgitation (TR) severity i.e. effective regurgitant orifice area (EROA) and regurgitant volume. Methods 382 patients with HFrEF on guideline-directed medical therapy were enrolled and TR EROA as well as regurgitant volume by Doppler/2D-echocardiography were assessed. All-cause mortality was defined as the primary study endpoint. Results Quantitative metrics of TR severity were consistently associated with mortality with a HR of 1.27 (95% CI 1.13–1.42, P<0.001) for the EROA and of 1.29 (95% CI 1.14–1.45, P<0.001) for the regurgitant volume (Figure 1, Panels A and B). Results remained unchanged after bootstrap- or clinical confounder-based adjustment. A spline curve pattern illustrates the association with mortality with thresholds for the EROA≥0.2cm2, and the regurgitant volume≥20ml with sustained excess mortality thereafter (Figure 1 Panels C-D). Figure 1. Panels A–D Conclusions This large-scale study demonstrates the prognostic value of quantitative measures of TR severity in HFrEF. Thresholds for EROA and TR regurgitant volume associated with mortality fall within current ranges defining non-severe TR. This may potentially impact therapeutic decision making particularly timing of intervention.
No takes yet. Share an insight, caveat, or question.
Bartko et al. (2019) conducted a cohort in Heart failure with reduced ejection fraction (HFrEF) and functional tricuspid regurgitation (n=382). Effective regurgitant orifice area (EROA) and regurgitant volume was evaluated on All-cause mortality (HR 1.27, 95% CI 1.13-1.42, p=<0.001). Higher effective regurgitant orifice area (HR 1.27; 95% CI 1.13-1.42) and regurgitant volume (HR 1.29; 95% CI 1.14-1.45) were significantly associated with increased all-cause mortality in HFrEF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: